ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,814 | +186.9% | 7,738 | +268.0% | 0.00% | 0.0% |
| Q2 2023 | $16,319 | +30690.6% | 2,103 | -76.8% | 0.00% | -50.0% |
| Q4 2022 | $53 | -99.8% | 9,077 | +30.3% | 0.00% | – |
| Q3 2022 | $22,000 | -60.0% | 6,967 | -42.4% | 0.00% | -100.0% |
| Q2 2022 | $55,000 | -41.5% | 12,093 | -31.0% | 0.00% | 0.0% |
| Q1 2022 | $94,000 | +683.3% | 17,530 | +2056.2% | 0.00% | – |
| Q4 2021 | $12,000 | -77.4% | 813 | -67.6% | 0.00% | -100.0% |
| Q3 2021 | $53,000 | +65.6% | 2,510 | +34.7% | 0.00% | 0.0% |
| Q2 2021 | $32,000 | -15.8% | 1,863 | +20.0% | 0.00% | 0.0% |
| Q1 2021 | $38,000 | -57.3% | 1,552 | -41.1% | 0.00% | -66.7% |
| Q4 2020 | $89,000 | -53.9% | 2,635 | -65.9% | 0.00% | +50.0% |
| Q3 2020 | $193,000 | +1186.7% | 7,728 | +1664.4% | 0.00% | +100.0% |
| Q2 2020 | $15,000 | – | 438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |